| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/JAMA.1953.63690150002009A |
| P698 | PubMed publication ID | 13061294 |
| P2093 | author name string | GOLDMAN L | |
| PRESTON RH | |||
| COLE DP | |||
| P433 | issue | 15 | |
| P921 | main subject | chloroquine | Q422438 |
| P304 | page(s) | 1428-1429 | |
| P577 | publication date | 1953-08-01 | |
| P1433 | published in | Journal of the American Medical Association | Q27718091 |
| P1476 | title | Chloroquine diphosphate in treatment of discoid lupus erythematosus | |
| P478 | volume | 152 |
| Q50059772 | A bibliometric review of drug repurposing |
| Q40244962 | Anti-malarials in dermatology |
| Q41925679 | Antimalarial therapy for lupus erythematosus: an apparent advantage of quinacrine |
| Q39772563 | Antimalarials in the management of discoid and systemic lupus erythematosus |
| Q34129797 | Antimalarials. |
| Q38242790 | Approaches for detecting lysosomal alkalinization and impaired degradation in fresh and cultured RPE cells: evidence for a role in retinal degenerations |
| Q41947452 | Atebrine and chloroquine/resochin therapy of lupus erythematous and dermatoses due to photosensitivity |
| Q33570457 | Chloroquine and rheumatoid arthritis; a short-term controlled trial |
| Q38503439 | Chloroquine-containing compounds: a patent review (2010 - 2014). |
| Q40481353 | Chloroquine: its therapeutic use in photosensitive eruptions |
| Q54218397 | Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review. |
| Q24240456 | Drugs for discoid lupus erythematosus |
| Q57692874 | Drugs for discoid lupus erythematosus |
| Q30234556 | Drugs for discoid lupus erythematosus. |
| Q71688323 | Gas chromatographic analysis of chloroquine after a unique reaction with chloroformates |
| Q41914995 | Kinetics of DNA binding with chloroquine phosphate using capacitive sensing method |
| Q41946684 | Lichenoid dermatitis due to chloroquine |
| Q41947565 | Light sensitive eruptions treated with atabrine and chloroquine |
| Q74658507 | Rationale for the treatment of lupus erythematosus with antimalarials |
| Q41573091 | Study of chloroquine toxicity and a drug-induced cerebrospinal lipodystrophy in swine |
| Q48792052 | The Recognition of Drug Effects |
| Q41947536 | The use of chloroquine diphosphate (aralen) and quinacrine (atabrine) hydrochloride in the prevention of polymorphorus light eruptions. |
| Q41946955 | Treatment of lupus erythematosus with chloroquine; therapeutic results and a comparison of the value of chloroquine and mepacrine |
| Q53569313 | Treatment of systemic lupus erythematosus: from cod-liver oil to cyclosporin. |
| Q97418806 | Two years' experience of screening for hydroxychloroquine retinopathy |
Search more.